|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Interest income | |||||
| Change in fair value of earnout liability | |||||
| Change in fair value of warrant liability | |||||
| Other income (expense), net | |||||
| Total other income, net | |||||
| Net loss and comprehensive loss | |||||
| Other expense, net | |||||
| Total other income, net | |||||
| Net loss and comprehensive loss | |||||
| Net loss per share attributable to common stockholders, basic (in Dollars per share) | |||||
| Net loss per share attributable to common stockholders, diluted (in Dollars per share) | |||||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares) | |||||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares) | |||||
Loading...